Galderma Group AG (PY3)
Market Closed
12 Jun, 20:00
€
186. 00
+1
+0.5405%
€
39.17B Market Cap
- P/E Ratio
- Div Yield
25 Volume
- Eps
€ 185
Previous Close Want to track PY3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Galderma Group AG (PY3) Statistics
Valuation metrics
Market Cap 39.17B
Enterprise value 36.21B
Trailing P/E (ttm) 76.92
Forward P/E -
PEG ratio -
Price/Sales (ttm) 7.61
Price/Book (mrq) 5.77
Enterprise Value/Revenue 8.03
Enterprise Value/EBITDA 37.11
Overview
Shares outstanding 234.57M
Float 96.82M
Shares short -
% Held by insiders 0.21%
% Held by institutions 0.41%
Average volume (10 days) 33
Average volume (90 days) 59
Price summary
52-Week low 114
52-Week high 199
Beta -0.05
50-Day moving average 168.76
200-Day moving average 159.69
Dividends and splits
Forward annual dividend rate 0.38
Forward annual dividend yield 0.0022%
Trailing annual dividend rate 0.44
Trailing annual dividend yield 0.0026%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 4 May 2026
Ex-Dividend Date 24 Apr 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.12%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.08%
Income Statement
Revenue (ttm) 4.51B
Revenue per share (ttm) 22.23
Quarterly revenue growth (yoy) 0.25%
Gross profit (ttm) 3.11B
EBITDA 1.19B
Net income to common (ttm) 527.49M
Diluted EPS (ttm) 2.21
Quarterly earnings growth (yoy) 1.28%
Balance Sheet
Total cash (mrq) 671.2M
Total cash per share (mrq) 3.33
Total debt (mrq) 2.37B
Total Debt/Equity (mrq) 33.8
Current ratio (mrq) 1.19%
Book value per share (mrq) 29.47
Cash Flow
Cash flow statement 1.02B
Levered free cash flow (LFCF) 778.76M
